The international trajectory of dissociative agents reflects a profound dual identity within modern science and public policy. Originally synthesized as a rapid-acting arylcyclohexylamine anesthetic, ketamine hydrochloride has steadily evolved from an operating room staple into a cornerstone of experimental psychopharmacology and treatment-resistant mood disorder management. As clinical investigators across North America, Europe, and Australasia refine […]